Evidence map›Paper›PMID 33760637›Full record

ArticleJCO oncology practice2021

Identification of Patient-Reported Outcome Phenotypes Among Oncology Patients With Palliative Care Needs.

Tara L Kaufmann, Kelly D Getz, Jesse Y Hsu, Antonia V Bennett, Samuel U Takvorian, Arif H Kamal, Angela DeMichele

Open access · bronzeAbstract read
In one paragraph

Article in JCO oncology practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Using Patient-Reported Outcome Measures to Identify Mobility Limitation in Incurable Cancer.Archives of rehabilitation research and clinical translation · 2026
    Article
  2. Developing the multidisciplinary and multispecialty workforce and the systems needed to sustain high-quality care from diagnosis through long-term survivorship.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Tara L KaufmannDivision of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.ORCID 0000-0002-8875-9462
Kelly D GetzDivision of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.ORCID 0000-0003-2020-5153
Jesse Y HsuUniversity of Pennsylvania, Philadelphia, PA.ORCID 0000-0002-1522-6534
Antonia V BennettCancer Outcomes Research Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.
Samuel U TakvorianDivision of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.ORCID 0000-0002-1173-3846
Arif H KamalDuke Cancer Institute, Durham, NC.ORCID 0000-0002-5235-9395
Angela DeMicheleDivision of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.ORCID 0000-0003-1297-4251
University of Pennsylvania · USAbramson Cancer CenterChildren's Hospital of Philadelphia · USDuke Medical Center · USLivestrong Foundation · USUniversity of North Carolina at Chapel Hill · US

Funding

CANCER CLINICAL EPIDEMIOLOGY TRAINING GRANTT32CA009679 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Richard Aplenc, Karen Glanz · 1992 to 2026
$11.1M
Palliative Care Research Cooperative Group (PCRC): Refinement and ExpansionU2CNR014637 · NINR · UNIVERSITY OF COLORADO DENVER · PI KUTNER, JEAN S, POLLAK, KATHRYN I · 2018 to 2022
$8.6M
Which palliative care quality measures improve patient-centered outcomes?K08HS023681 · AHRQ · DUKE UNIVERSITY · PI KAMAL, ARIF · 2015 to 2019
$733k
Early Treatment-Related Cardiotoxicity and Subsequent Outcomes in Pediatric Acute Myeloid Leukemia: an Assessment of Development, Progression and MitigationK01HL143153 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI GETZ, KELLY DIRINGER · 2018 to 2022
$716k
AHRQ HHS K08 HS023681NCI NIH HHS T32 CA009679NHLBI NIH HHS K01 HL143153NINR NIH HHS U2C NR014637
6 · The paper itself

Abstract

purposeDespite evidence-based guidelines recommending early palliative care, it remains unclear how to identify and refer oncology patients, particularly in settings with constrained access to palliative care. We hypothesize that patient-reported outcome (PRO) data can be used to characterize patients with palliative care needs. To determine if PRO data can identify latent phenotypes that characterize indications for specialty palliative care referral.

methodsWe conducted a retrospective study of self-reported symptoms on the Edmonton Symptom Assessment System collected from solid tumor oncology patients (n = 745) referred to outpatient palliative care. Data were collected as part of routine clinical care from October 2012 to March 2018 at eight community and academic sites. We applied latent profile analysis to identify PRO phenotypes and examined the association of phenotypes with clinical and demographic characteristics using multinomial logistic regression.

resultsWe identified four PRO phenotypes: (1) Low Symptoms (n = 295, 39.6%), (2) Moderate Pain/Fatigue + Mood (n = 180, 24.2%), (3) Moderate Pain/Fatigue + Appetite + Dyspnea (n = 201, 27.0%), and (4) High Symptoms (n = 69, 9.3%). In a secondary analysis of 421 patients, we found that two brief items assessing social and existential needs aligned with higher severity symptom and psychological distress phenotypes.

conclusionOncology patients referred to outpatient palliative care in a real-world setting can be differentiated into clinically meaningful phenotypes using brief, routinely collected PRO measures. Latent modeling provides a mechanism to use patient-reported data on a population level to identify distinct subgroups of patients with unmet palliative needs.

Indexed as

NeoplasmsPalliative CareHumansPatient Reported Outcome MeasuresPhenotypeRetrospective Studies

Identifiers

PMID33760637
PMCPMC8791824
OpenAlexW3136954419

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.